A citation-based method for searching scientific literature

William C Black, Ilana F Gareen, Samir S Soneji, JoRean D Sicks, Emmett B Keeler, Denise R Aberle, Arash Naeim, Timothy R Church, Gerard A Silvestri, Jeremy Gorelick, Constantine Gatsonis. N Engl J Med 2014
Times Cited: 342







List of co-cited articles
622 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
80

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
Harry J de Koning, Carlijn M van der Aalst, Pim A de Jong, Ernst T Scholten, Kristiaan Nackaerts, Marjolein A Heuvelmans, Jan-Willem J Lammers, Carla Weenink, Uraujh Yousaf-Khan, Nanda Horeweg,[...]. N Engl J Med 2020
958
43


Selection criteria for lung-cancer screening.
Martin C Tammemägi, Hormuzd A Katki, William G Hocking, Timothy R Church, Neil Caporaso, Paul A Kvale, Anil K Chaturvedi, Gerard A Silvestri, Tom L Riley, John Commins,[...]. N Engl J Med 2013
536
22

European position statement on lung cancer screening.
Matthijs Oudkerk, Anand Devaraj, Rozemarijn Vliegenthart, Thomas Henzler, Helmut Prosch, Claus P Heussel, Gorka Bastarrika, Nicola Sverzellati, Mario Mascalchi, Stefan Delorme,[...]. Lancet Oncol 2017
300
21

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
Alex H Krist, Karina W Davidson, Carol M Mangione, Michael J Barry, Michael Cabana, Aaron B Caughey, Esa M Davis, Katrina E Donahue, Chyke A Doubeni, Martha Kubik,[...]. JAMA 2021
315
21

Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Paul F Pinsky, David S Gierada, William Black, Reginald Munden, Hrudaya Nath, Denise Aberle, Ella Kazerooni. Ann Intern Med 2015
287
20


UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
J K Field, S W Duffy, D R Baldwin, D K Whynes, A Devaraj, K E Brain, T Eisen, J Gosney, B A Green, J A Holemans,[...]. Thorax 2016
197
19

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.
Sonya Cressman, Stuart J Peacock, Martin C Tammemägi, William K Evans, Natasha B Leighl, John R Goffin, Alain Tremblay, Geoffrey Liu, Daria Manos, Paul MacEachern,[...]. J Thorac Oncol 2017
76
23

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
Harry J de Koning, Rafael Meza, Sylvia K Plevritis, Kevin ten Haaf, Vidit N Munshi, Jihyoun Jeon, Saadet Ayca Erdogan, Chung Yin Kong, Summer S Han, Joost van Rosmalen,[...]. Ann Intern Med 2014
327
17

Cost-effectiveness of computed tomography screening for lung cancer in the United States.
Pamela M McMahon, Chung Yin Kong, Colleen Bouzan, Milton C Weinstein, Lauren E Cipriano, Angela C Tramontano, Bruce E Johnson, Jane C Weeks, G Scott Gazelle. J Thorac Oncol 2011
168
17

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Vaibhav Kumar, Joshua T Cohen, David van Klaveren, Djøra I Soeteman, John B Wong, Peter J Neumann, David M Kent. Ann Intern Med 2018
59
27

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
John K Field, Stephen W Duffy, David R Baldwin, Kate E Brain, Anand Devaraj, Tim Eisen, Beverley A Green, John A Holemans, Terry Kavanagh, Keith M Kerr,[...]. Health Technol Assess 2016
142
16

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat. PLoS Med 2017
85
17

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza. PLoS Med 2017
152
15

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.
Heber MacMahon, David P Naidich, Jin Mo Goo, Kyung Soo Lee, Ann N C Leung, John R Mayo, Atul C Mehta, Yoshiharu Ohno, Charles A Powell, Mathias Prokop,[...]. Radiology 2017
15

Targeting of low-dose CT screening according to the risk of lung-cancer death.
Stephanie A Kovalchik, Martin Tammemagi, Christine D Berg, Neil E Caporaso, Tom L Riley, Mary Korch, Gerard A Silvestri, Anil K Chaturvedi, Hormuzd A Katki. N Engl J Med 2013
392
15

Benefits and harms of CT screening for lung cancer: a systematic review.
Peter B Bach, Joshua N Mirkin, Thomas K Oliver, Christopher G Azzoli, Donald A Berry, Otis W Brawley, Tim Byers, Graham A Colditz, Michael K Gould, James R Jett,[...]. JAMA 2012
823
14

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
14


Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Cristiano Rampinelli, Paolo De Marco, Daniela Origgi, Patrick Maisonneuve, Monica Casiraghi, Giulia Veronesi, Lorenzo Spaggiari, Massimo Bellomi. BMJ 2017
132
14

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Hormuzd A Katki, Stephanie A Kovalchik, Christine D Berg, Li C Cheung, Anil K Chaturvedi. JAMA 2016
173
13

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
U Pastorino, M Silva, S Sestini, F Sabia, M Boeri, A Cantarutti, N Sverzellati, G Sozzi, G Corrao, A Marchianò. Ann Oncol 2019
135
13

Cost-effectiveness of Lung Cancer Screening in Canada.
John R Goffin, William M Flanagan, Anthony B Miller, Natalie R Fitzgerald, Saima Memon, Michael C Wolfson, William K Evans. JAMA Oncol 2015
63
20

Probability of cancer in pulmonary nodules detected on first screening CT.
Annette McWilliams, Martin C Tammemagi, John R Mayo, Heidi Roberts, Geoffrey Liu, Kam Soghrati, Kazuhiro Yasufuku, Simon Martel, Francis Laberge, Michel Gingras,[...]. N Engl J Med 2013
697
13

Overdiagnosis in low-dose computed tomography screening for lung cancer.
Edward F Patz, Paul Pinsky, Constantine Gatsonis, Jorean D Sicks, Barnett S Kramer, Martin C Tammemägi, Caroline Chiles, William C Black, Denise R Aberle. JAMA Intern Med 2014
501
13

Results of initial low-dose computed tomographic screening for lung cancer.
Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones,[...]. N Engl J Med 2013
675
12

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Eugenio Paci, Donella Puliti, Andrea Lopes Pegna, Laura Carrozzi, Giulia Picozzi, Fabio Falaschi, Francesco Pistelli, Ferruccio Aquilini, Cristina Ocello, Marco Zappa,[...]. Thorax 2017
141
12

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
Yuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, Malcolm Kohler, Roger D Kouyos, Mohaned Shilaih, Matthias Lorez, Harry J de Koning, Matthias Schwenkglenks, Milo A Puhan. Lung Cancer 2018
30
40

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Steven D Criss, Pianpian Cao, Mehrad Bastani, Kevin Ten Haaf, Yufan Chen, Deirdre F Sheehan, Erik F Blom, Iakovos Toumazis, Jihyoun Jeon, Harry J de Koning,[...]. Ann Intern Med 2019
45
26

The National Lung Screening Trial: overview and study design.
Denise R Aberle, Christine D Berg, William C Black, Timothy R Church, Richard M Fagerstrom, Barbara Galen, Ilana F Gareen, Constantine Gatsonis, Jonathan Goldin, John K Gohagan,[...]. Radiology 2011
720
12

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Nikolaus Becker, Erna Motsch, Anke Trotter, Claus P Heussel, Hendrik Dienemann, Philipp A Schnabel, Hans-Ulrich Kauczor, Sandra González Maldonado, Anthony B Miller, Rudolf Kaaks,[...]. Int J Cancer 2020
145
12

Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
Douglas E Wood, Ella A Kazerooni, Scott L Baum, George A Eapen, David S Ettinger, Lifang Hou, David M Jackman, Donald Klippenstein, Rohit Kumar, Rudy P Lackner,[...]. J Natl Compr Canc Netw 2018
285
11

Management of lung nodules detected by volume CT scanning.
Rob J van Klaveren, Matthijs Oudkerk, Mathias Prokop, Ernst T Scholten, Kristiaan Nackaerts, Rene Vernhout, Carola A van Iersel, Karien A M van den Bergh, Susan van 't Westeinde, Carlijn van der Aalst,[...]. N Engl J Med 2009
589
11

Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
Adam J N Raymakers, John Mayo, Stephen Lam, J Mark FitzGerald, David G T Whitehurst, Larry D Lynd. Appl Health Econ Health Policy 2016
41
26

British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
M E J Callister, D R Baldwin, A R Akram, S Barnard, P Cane, J Draffan, K Franks, F Gleeson, R Graham, P Malhotra,[...]. Thorax 2015
454
11


Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.
Ugo Pastorino, Marta Rossi, Valentina Rosato, Alfonso Marchianò, Nicola Sverzellati, Carlo Morosi, Alessandra Fabbri, Carlotta Galeone, Eva Negri, Gabriella Sozzi,[...]. Eur J Cancer Prev 2012
300
11

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
Kate Brain, Kate J Lifford, Ben Carter, Olivia Burke, Fiona McRonald, Anand Devaraj, David M Hansell, David Baldwin, Stephen W Duffy, John K Field. Thorax 2016
55
20

Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis.
Bruce S Pyenson, Claudia I Henschke, David F Yankelevitz, Rowena Yip, Ellynne Dec. Am Health Drug Benefits 2014
56
17

Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Tristan Snowsill, Huiqin Yang, Ed Griffin, Linda Long, Jo Varley-Campbell, Helen Coelho, Sophie Robinson, Chris Hyde. Health Technol Assess 2018
48
20

The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
Jesper H Pedersen, Haseem Ashraf, Asger Dirksen, Karen Bach, Hanne Hansen, Phillip Toennesen, Hanne Thorsen, John Brodersen, Birgit Guldhammer Skov, Martin Døssing,[...]. J Thorac Oncol 2009
277
10

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
10

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.
Diego Ardila, Atilla P Kiraly, Sujeeth Bharadwaj, Bokyung Choi, Joshua J Reicher, Lily Peng, Daniel Tse, Mozziyar Etemadi, Wenxing Ye, Greg Corrado,[...]. Nat Med 2019
524
10

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Maurizio Infante, Silvio Cavuto, Fabio Romano Lutman, Eliseo Passera, Maurizio Chiarenza, Giuseppe Chiesa, Giorgio Brambilla, Enzo Angeli, Giuseppe Aranzulla, Arturo Chiti,[...]. Am J Respir Crit Care Med 2015
220
10

Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Andrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, Laura Carrozzi, Massimo Falchini, Francesca Maria Carozzi, Francesco Pistelli, Camilla Comin, Annalisa Deliperi, Michela Grazzini,[...]. J Thorac Oncol 2013
86
11

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Uraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, Marjolein Heuvelmans, Ernst Scholten, Jan-Willem Lammers, Peter van Ooijen, Kristiaan Nackaerts, Carla Weenink, Harry Groen,[...]. Thorax 2017
158
10

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Nanda Horeweg, Ernst Th Scholten, Pim A de Jong, Carlijn M van der Aalst, Carla Weenink, Jan-Willem J Lammers, Kristiaan Nackaerts, Rozemarijn Vliegenthart, Kevin ten Haaf, Uraujh A Yousaf-Khan,[...]. Lancet Oncol 2014
211
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.